# EDGAR Filing Document

**Accession Number:** 0001859795
**File Stem:** 0001193125-25-241555
**Filing Date:** 2025-10
**Character Count:** 31948
**Document Hash:** 88805eec50a3e01076fcff4b906e8f6c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-241555.hdr.sgml**: 20251016

**ACCESSION NUMBER**: 0001193125-25-241555

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251017

**FILED AS OF DATE**: 20251016

**DATE AS OF CHANGE**: 20251016

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NOVONIX Ltd
- **CENTRAL INDEX KEY:** 0001859795
- **STANDARD INDUSTRIAL CLASSIFICATION:** MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 981559131
- **STATE OF INCORPORATION:** C3
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41208
- **FILM NUMBER:** 251398387

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** LEVEL 38
- **STREET 2:** 71 EAGLE STREET
- **CITY:** BRISBANE
- **PROVINCE COUNTRY:** C3
- **BUSINESS PHONE:** 4235416874

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** LEVEL 38
- **STREET 2:** 71 EAGLE STREET
- **CITY:** BRISBANE
- **PROVINCE COUNTRY:** C3

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

Washington, D.C. 20549

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE**

**SECURITIES EXCHANGE ACT OF 1934**

For the month of October, 2025

001-41208 <br> (Commission File Number)

**NOVONIX LIMITED**

(Translation of registrant's name into English)

Level 38

71 Eagle Street

Brisbane, QLD 4000 Australia

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

------

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| **<u>Exhibit No.</u>** | **<u>Description</u>** |
| Exhibit 99.1 | [<u>ASX Announcement (NOVONIX Achieves Critical Operational Milestone) dated October 15, 2025.</u>](nvx-ex99_1.htm) |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| **NOVONIX LIMITED** | **NOVONIX LIMITED** |
| By: | <u>/s/ Robert Long</u> |
|  | Robert Long |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chief Financial Officer |

---

Date: October 17, 2025

------

## Exhibit 99.1

**Exhibit 99.1**

Docusign Envelope ID: C08E36EC-FA82-485A-869C-B6CD7E7F3F5D

603 page 1/2 15 July 2018

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| <br>**Form 603**<br>**Corporations Act 2001**<br>**Section 671B**<br>**Notice of initial substantial holder** | <br>**Form 603**<br>**Corporations Act 2001**<br>**Section 671B**<br>**Notice of initial substantial holder** | <br>**Form 603**<br>**Corporations Act 2001**<br>**Section 671B**<br>**Notice of initial substantial holder** | <br>**Form 603**<br>**Corporations Act 2001**<br>**Section 671B**<br>**Notice of initial substantial holder** | <br>**Form 603**<br>**Corporations Act 2001**<br>**Section 671B**<br>**Notice of initial substantial holder** | <br>**Form 603**<br>**Corporations Act 2001**<br>**Section 671B**<br>**Notice of initial substantial holder** |
| &nbsp;&nbsp;To Company/registered<br>scheme/notified foreign<br>passport fund name<br>ACN/ARSN/APFRN<br>NFPFRN (if applicable)<br>**1. Details of substantial holder (1)**<br>Name<br>ACN/ARSN/APFRN (if applicable)<br>NFPFRN (if applicable) | &nbsp;&nbsp;&nbsp;&nbsp; <br>Novonix Limited | &nbsp;&nbsp;&nbsp;&nbsp; <br>Novonix Limited | &nbsp;&nbsp;&nbsp;&nbsp; <br>Novonix Limited | &nbsp;&nbsp;&nbsp;&nbsp; <br>Novonix Limited | &nbsp;&nbsp;&nbsp;&nbsp; <br>Novonix Limited |
| &nbsp;&nbsp;To Company/registered<br>scheme/notified foreign<br>passport fund name<br>ACN/ARSN/APFRN<br>NFPFRN (if applicable)<br>**1. Details of substantial holder (1)**<br>Name<br>ACN/ARSN/APFRN (if applicable)<br>NFPFRN (if applicable) |  |  |  |  |  |
| &nbsp;&nbsp;To Company/registered<br>scheme/notified foreign<br>passport fund name<br>ACN/ARSN/APFRN<br>NFPFRN (if applicable)<br>**1. Details of substantial holder (1)**<br>Name<br>ACN/ARSN/APFRN (if applicable)<br>NFPFRN (if applicable) | &nbsp;&nbsp;157 690 830 | &nbsp;&nbsp;157 690 830 | &nbsp;&nbsp;157 690 830 | &nbsp;&nbsp;157 690 830 | &nbsp;&nbsp;157 690 830 |
| &nbsp;&nbsp;To Company/registered<br>scheme/notified foreign<br>passport fund name<br>ACN/ARSN/APFRN<br>NFPFRN (if applicable)<br>**1. Details of substantial holder (1)**<br>Name<br>ACN/ARSN/APFRN (if applicable)<br>NFPFRN (if applicable) | <br>YA II PN, Ltd. | <br>YA II PN, Ltd. | <br>YA II PN, Ltd. | <br>YA II PN, Ltd. | <br>YA II PN, Ltd. |
| &nbsp;&nbsp;To Company/registered<br>scheme/notified foreign<br>passport fund name<br>ACN/ARSN/APFRN<br>NFPFRN (if applicable)<br>**1. Details of substantial holder (1)**<br>Name<br>ACN/ARSN/APFRN (if applicable)<br>NFPFRN (if applicable) |  |  |  |  |  |
| &nbsp;&nbsp;To Company/registered<br>scheme/notified foreign<br>passport fund name<br>ACN/ARSN/APFRN<br>NFPFRN (if applicable)<br>**1. Details of substantial holder (1)**<br>Name<br>ACN/ARSN/APFRN (if applicable)<br>NFPFRN (if applicable) |  |  |  |  |  |
| &nbsp;&nbsp;To Company/registered<br>scheme/notified foreign<br>passport fund name<br>ACN/ARSN/APFRN<br>NFPFRN (if applicable)<br>**1. Details of substantial holder (1)**<br>Name<br>ACN/ARSN/APFRN (if applicable)<br>NFPFRN (if applicable) |  |  |  |  |  |
| &nbsp;&nbsp;The holder became a substantial holder on | &nbsp;&nbsp;The holder became a substantial holder on | <u>13</u> <u>/</u> <u>10</u> <u>/</u> <u>20</u>25 |  |  |  |
| &nbsp;&nbsp;**2. Details of voting power**<br>The total number of votes attached to all the voting shares or interests in the company, scheme or fund that the substantial holder or an associate (2) had a relevant interest (3) in on the date the substantial holder became a substantial holder are as follows: | &nbsp;&nbsp;**2. Details of voting power**<br>The total number of votes attached to all the voting shares or interests in the company, scheme or fund that the substantial holder or an associate (2) had a relevant interest (3) in on the date the substantial holder became a substantial holder are as follows: | &nbsp;&nbsp;**2. Details of voting power**<br>The total number of votes attached to all the voting shares or interests in the company, scheme or fund that the substantial holder or an associate (2) had a relevant interest (3) in on the date the substantial holder became a substantial holder are as follows: | &nbsp;&nbsp;**2. Details of voting power**<br>The total number of votes attached to all the voting shares or interests in the company, scheme or fund that the substantial holder or an associate (2) had a relevant interest (3) in on the date the substantial holder became a substantial holder are as follows: | &nbsp;&nbsp;**2. Details of voting power**<br>The total number of votes attached to all the voting shares or interests in the company, scheme or fund that the substantial holder or an associate (2) had a relevant interest (3) in on the date the substantial holder became a substantial holder are as follows: | &nbsp;&nbsp;**2. Details of voting power**<br>The total number of votes attached to all the voting shares or interests in the company, scheme or fund that the substantial holder or an associate (2) had a relevant interest (3) in on the date the substantial holder became a substantial holder are as follows: |
| &nbsp;&nbsp;&nbsp;Class of securities (4) | &nbsp;&nbsp;&nbsp;Class of securities (4) | &nbsp;&nbsp;&nbsp;Number of securities | &nbsp;&nbsp;&nbsp;Person's votes (5) | &nbsp;&nbsp;&nbsp;Person's votes (5) | &nbsp;&nbsp;&nbsp;Voting power (6) |
| &nbsp;&nbsp;&nbsp;Fully paid ordinary shares | &nbsp;&nbsp;&nbsp;Fully paid ordinary shares | &nbsp;&nbsp;87358939 | &nbsp;&nbsp;87358939 | &nbsp;&nbsp;87358939 | &nbsp;&nbsp;11.03% |
| &nbsp;&nbsp;**3. Details of relevant interests**<br>The nature of the relevant interest the substantial holder or an associate had in the following voting securities on the date the substantial holder became a substantial holder are as follows: | &nbsp;&nbsp;**3. Details of relevant interests**<br>The nature of the relevant interest the substantial holder or an associate had in the following voting securities on the date the substantial holder became a substantial holder are as follows: | &nbsp;&nbsp;**3. Details of relevant interests**<br>The nature of the relevant interest the substantial holder or an associate had in the following voting securities on the date the substantial holder became a substantial holder are as follows: | &nbsp;&nbsp;**3. Details of relevant interests**<br>The nature of the relevant interest the substantial holder or an associate had in the following voting securities on the date the substantial holder became a substantial holder are as follows: | &nbsp;&nbsp;**3. Details of relevant interests**<br>The nature of the relevant interest the substantial holder or an associate had in the following voting securities on the date the substantial holder became a substantial holder are as follows: | &nbsp;&nbsp;**3. Details of relevant interests**<br>The nature of the relevant interest the substantial holder or an associate had in the following voting securities on the date the substantial holder became a substantial holder are as follows: |
| &nbsp;&nbsp;&nbsp;&nbsp;Holder of relevant interest | &nbsp;&nbsp;&nbsp;&nbsp;Holder of relevant interest | &nbsp;&nbsp;Nature of relevant interest (7) | &nbsp;&nbsp;Nature of relevant interest (7) | &nbsp;&nbsp;Class and number of securities | &nbsp;&nbsp;Class and number of securities |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Annexure A | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Annexure A |  |  |  |  |
| <br>**4. Details of present registered holders**<br>The persons registered as holders of the securities referred to in paragraph 3 above are as follows: | <br>**4. Details of present registered holders**<br>The persons registered as holders of the securities referred to in paragraph 3 above are as follows: | <br>**4. Details of present registered holders**<br>The persons registered as holders of the securities referred to in paragraph 3 above are as follows: | <br>**4. Details of present registered holders**<br>The persons registered as holders of the securities referred to in paragraph 3 above are as follows: | <br>**4. Details of present registered holders**<br>The persons registered as holders of the securities referred to in paragraph 3 above are as follows: | <br>**4. Details of present registered holders**<br>The persons registered as holders of the securities referred to in paragraph 3 above are as follows: |
| &nbsp;&nbsp;&nbsp;&nbsp;Holder of relevant<br>interest | &nbsp;&nbsp;&nbsp;&nbsp;Holder of relevant<br>interest | &nbsp;&nbsp;&nbsp;&nbsp;Registered holder of<br>securities | &nbsp;&nbsp;&nbsp;&nbsp;Person entitled to be<br>registered as holder (8) | &nbsp;&nbsp;&nbsp;&nbsp;Person entitled to be<br>registered as holder (8) | &nbsp;&nbsp;&nbsp;&nbsp;Class and<br>number of<br>securities |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Annexure A | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Annexure A |  |  |  |  |
| <br>**5. Consideration**<br>The consideration paid for each relevant interest referred to in paragraph 3 above, and acquired in the four months prior to the day that the substantial holder became a substantial holder is as follows: | <br>**5. Consideration**<br>The consideration paid for each relevant interest referred to in paragraph 3 above, and acquired in the four months prior to the day that the substantial holder became a substantial holder is as follows: | <br>**5. Consideration**<br>The consideration paid for each relevant interest referred to in paragraph 3 above, and acquired in the four months prior to the day that the substantial holder became a substantial holder is as follows: | <br>**5. Consideration**<br>The consideration paid for each relevant interest referred to in paragraph 3 above, and acquired in the four months prior to the day that the substantial holder became a substantial holder is as follows: | <br>**5. Consideration**<br>The consideration paid for each relevant interest referred to in paragraph 3 above, and acquired in the four months prior to the day that the substantial holder became a substantial holder is as follows: | <br>**5. Consideration**<br>The consideration paid for each relevant interest referred to in paragraph 3 above, and acquired in the four months prior to the day that the substantial holder became a substantial holder is as follows: |
| &nbsp;&nbsp;&nbsp;&nbsp;Holder of relevant<br>interest | &nbsp;&nbsp;&nbsp;&nbsp;Holder of relevant<br>interest | &nbsp;&nbsp;&nbsp;&nbsp;Date of acquisition | &nbsp;&nbsp;&nbsp;&nbsp;Consideration (9) | &nbsp;&nbsp;&nbsp;&nbsp;Consideration (9) | &nbsp;&nbsp;&nbsp;&nbsp;Class and<br>number of<br>securities |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Annexure B | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Annexure B |  | &nbsp;&nbsp;Cash | &nbsp;&nbsp;Non-cash |  |

---

------

Docusign Envelope ID: C08E36EC-FA82-485A-869C-B6CD7E7F3F5D

603 page 2/2 15 July 2018

---

| | | | |
|:---|:---|:---|:---|
| <br>**6. Associates**<br>The reasons the persons named in paragraph 3 above are associates of the substantial holder are as follows: | <br>**6. Associates**<br>The reasons the persons named in paragraph 3 above are associates of the substantial holder are as follows: | <br>**6. Associates**<br>The reasons the persons named in paragraph 3 above are associates of the substantial holder are as follows: | <br>**6. Associates**<br>The reasons the persons named in paragraph 3 above are associates of the substantial holder are as follows: |
| &nbsp;&nbsp;Name and ACN/ARSN/APFRN (if<br>applicable) and NFPFRN (if<br>applicable) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nature of association | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nature of association | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nature of association |
| &nbsp;&nbsp;**7. Addresses**<br>The addresses of persons named in this form are as follows: | &nbsp;&nbsp;**7. Addresses**<br>The addresses of persons named in this form are as follows: | &nbsp;&nbsp;**7. Addresses**<br>The addresses of persons named in this form are as follows: | &nbsp;&nbsp;**7. Addresses**<br>The addresses of persons named in this form are as follows: |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Address | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Address | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Address |
| &nbsp;&nbsp;&nbsp;&nbsp;YA II PN, Ltd. | &nbsp;&nbsp;&nbsp;&nbsp;102 Springfield Ave, Mountainside, New Jersey 07092 | &nbsp;&nbsp;&nbsp;&nbsp;102 Springfield Ave, Mountainside, New Jersey 07092 | &nbsp;&nbsp;&nbsp;&nbsp;102 Springfield Ave, Mountainside, New Jersey 07092 |
| &nbsp;&nbsp; <br>Signature  | &nbsp;&nbsp; <br>Signature  | &nbsp;&nbsp; <br>Signature  | &nbsp;&nbsp; <br>Signature  |
| &nbsp;&nbsp;print name  | David Gonzalez | &nbsp;&nbsp;capacity | Director |
| **sign here**  | /s/ David Gonzalez | &nbsp;&nbsp;date  | 14/ 10/ 2025 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**DIRECTIONS**<br>(1)If there are a number of substantial holders with similar or related relevant interests (eg. A corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 7of the form.<br>(2)See the definition of "associate" in section 9 of the Corporations Act 2001.<br>(3)See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.<br>(4)The voting shares of a company constitute one class unless divided into separate classes.<br>(5)The total number of votes attached to all the voting shares or interests in the company, scheme or fund (if any) that the person or an associate has a relevant interest in.<br>(6)The person's votes divided by the total votes in the body corporate, scheme or fund multiplied by 100.<br>(7)Include details of:<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)any relevant agreement or other circumstances by which the relevant interest was acquired. If subsection 671B(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).<br>See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.<br>(8)If the substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write "unknown".<br>(9)Details of the consideration must include any and all benefits, money and otherwise, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**DIRECTIONS**<br>(1)If there are a number of substantial holders with similar or related relevant interests (eg. A corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 7of the form.<br>(2)See the definition of "associate" in section 9 of the Corporations Act 2001.<br>(3)See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.<br>(4)The voting shares of a company constitute one class unless divided into separate classes.<br>(5)The total number of votes attached to all the voting shares or interests in the company, scheme or fund (if any) that the person or an associate has a relevant interest in.<br>(6)The person's votes divided by the total votes in the body corporate, scheme or fund multiplied by 100.<br>(7)Include details of:<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)any relevant agreement or other circumstances by which the relevant interest was acquired. If subsection 671B(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).<br>See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.<br>(8)If the substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write "unknown".<br>(9)Details of the consideration must include any and all benefits, money and otherwise, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**DIRECTIONS**<br>(1)If there are a number of substantial holders with similar or related relevant interests (eg. A corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 7of the form.<br>(2)See the definition of "associate" in section 9 of the Corporations Act 2001.<br>(3)See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.<br>(4)The voting shares of a company constitute one class unless divided into separate classes.<br>(5)The total number of votes attached to all the voting shares or interests in the company, scheme or fund (if any) that the person or an associate has a relevant interest in.<br>(6)The person's votes divided by the total votes in the body corporate, scheme or fund multiplied by 100.<br>(7)Include details of:<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)any relevant agreement or other circumstances by which the relevant interest was acquired. If subsection 671B(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).<br>See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.<br>(8)If the substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write "unknown".<br>(9)Details of the consideration must include any and all benefits, money and otherwise, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**DIRECTIONS**<br>(1)If there are a number of substantial holders with similar or related relevant interests (eg. A corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 7of the form.<br>(2)See the definition of "associate" in section 9 of the Corporations Act 2001.<br>(3)See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.<br>(4)The voting shares of a company constitute one class unless divided into separate classes.<br>(5)The total number of votes attached to all the voting shares or interests in the company, scheme or fund (if any) that the person or an associate has a relevant interest in.<br>(6)The person's votes divided by the total votes in the body corporate, scheme or fund multiplied by 100.<br>(7)Include details of:<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)any relevant agreement or other circumstances by which the relevant interest was acquired. If subsection 671B(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).<br>See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.<br>(8)If the substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write "unknown".<br>(9)Details of the consideration must include any and all benefits, money and otherwise, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired. |

---

------

Docusign Envelope ID: C08E36EC-FA82-485A-869C-B6CD7E7F3F5D

603GUIDE page 1/1 15 July 2018

---

| | |
|:---|:---|
| **GUIDE** | &nbsp;&nbsp;&nbsp;**This guide does not form part of the prescribed form and is included by ASIC to assist you in completing and lodging form 603.** |
| **Signature** | &nbsp;&nbsp;&nbsp;&nbsp;**Company** - form must be signed by a director or secretary.<br>**Foreign company** – form may be signed by the local agent, or if the local agent is a company, a director or secretary of the company.<br>**Registered scheme** – form must be signed by director or secretary of the responsible entity. |
| **Lodging period** | &nbsp;&nbsp;&nbsp;&nbsp;Nil |
| **Lodging Fee** | &nbsp;&nbsp;&nbsp;&nbsp;Nil |
| **Other forms to be completed** | &nbsp;&nbsp;&nbsp;&nbsp;Nil |
| **Additional**<br>**information** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)If additional space is required to complete a question, the information may be included on a separate piece of paper annexed to the form.<br>&nbsp;&nbsp;&nbsp;&nbsp;(b)This notice must be given to a listed company, or the responsible entity for a registered scheme, or the operator of a notified foreign passport fund. A copy of this notice must also be given to each relevant securities exchange.<br>&nbsp;&nbsp;&nbsp;&nbsp;(c)The person must give a copy of this notice:<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)within 2 business days after they become aware of the information; or<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)by 9.30 am on the next trading day of the relevant securities exchange after they become aware of the information if:<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)a takeover bid is made for voting shares or interests in the company or registered scheme; and<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)the person becomes aware of the information during the bid period. |
| **Annexures** |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;To make any annexure conform to the regulations, you must<br>1use A4 size paper of white or light pastel colour with a margin of at least 10mm on all sides<br>2show the corporation/registered scheme/notified foreign passport fund name and ACN/ARBN/ARSN and APFRN (if applicable) and NFPFRN (if applicable)<br>3number the pages consecutively<br>4print or type in BLOCK letters in dark blue or black ink so that the document is clearly legible when photocopied<br>5identify the annexure with a mark such as A, B, C, etc<br>6endorse the annexure with the words:<br>*This is annexure (mark) of (number) pages referred to in form (form number and title)*<br>7sign and date the annexure<br>The annexure must be signed by the same person(s) who signed the form. |
| **Information in this guide is intended as a guide only. Please consult your accountant or solicitor for further advice.** | **Information in this guide is intended as a guide only. Please consult your accountant or solicitor for further advice.** |

---

------

Docusign Envelope ID: C08E36EC-FA82-485A-869C-B6CD7E7F3F5D

This is Annexure A of 1 page referred to in Form 603 Notice of initial substantial holder in relation to Novonix Limited (ACN 157 690 830).

---

| |
|:---|
| /s/ David Gonzalez |
| David Gonzalez |
| 14 October 2025 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;**Holder of<br>Relevant<br>Interest** | &nbsp;&nbsp;**Nature of Relevant Interest** | &nbsp;&nbsp;**Registered**<br>**Holder of**<br>**Securities** | &nbsp;&nbsp;**Person**<br>**Entitled to**<br>**be**<br>**Registered**<br>**as Holder** | &nbsp;&nbsp;**Class and Number of**<br>**Securities** |
| &nbsp;&nbsp;YA II PN,<br>Ltd. | &nbsp;&nbsp;Relevant interest under<br>paragraph 608(1)(a) as<br>registered holder of Shares. | &nbsp;&nbsp;YA II PN,<br>Ltd. | &nbsp;&nbsp;YA II PN,<br>Ltd. | &nbsp;&nbsp;87,358,939 fully paid<br>ordinary shares |

---

------

Docusign Envelope ID: C08E36EC-FA82-485A-869C-B6CD7E7F3F5D

This is Annexure B of 1 page referred to in Form 603 Notice of initial substantial holder in relation to Novonix Limited (ACN 157 690 830).

---

| |
|:---|
| /s/ David Gonzalez |
| David Gonzalez |
| 14 October 2025 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;**Holder of**<br>**Relevant**<br>**Interest** | &nbsp;&nbsp;**Date of**<br>**Acquisition** | &nbsp;&nbsp;**Nature of Transaction** | &nbsp;&nbsp;**Consideration** | &nbsp;&nbsp;**Class and Number of**<br>**Securities** |
| &nbsp;&nbsp;YA II PN,<br>Ltd. | &nbsp;&nbsp;10/09/2025 | &nbsp;&nbsp;Exercise of convertible<br>securities held by YA II<br>PN, Ltd. | &nbsp;&nbsp;N/A | &nbsp;&nbsp;19,299,170 fully paid<br>ordinary shares |
| &nbsp;&nbsp;YA II PN,<br>Ltd. | &nbsp;&nbsp;13/10/2025 | &nbsp;&nbsp;Exercise of convertible<br>securities held by YA II<br>PN, Ltd. | &nbsp;&nbsp;N/A | &nbsp;&nbsp;68,059,769 fully paid<br>ordinary shares |

---

------